Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCM.L Regulatory News (TCM)

  • There is currently no data for TCM

Trading Statement

10 Oct 2013 07:00

RNS Number : 1583Q
Telit Communications PLC
10 October 2013
 



TELIT COMMUNICATIONS PLC

("Telit" or the "Company")

 

Trading Update for nine months ended 30 September 2013 and full year trading outlook

 

 

October 10, 2013 - The Board of Telit (AIM: TCM), a leading machine-to-machine wireless technology company, is pleased to provide a trading update for the nine months ended 30 September 2013.

 

Telit's revenues for the 3 months ended 30 September 2013 were $62.5 million (3 months 2012: $51.4 million), which represents a quarterly growth of 21.6%, compared to 2012. For the nine months ended 30 September 2013, revenues were $171 million (9 months 2012: $150 million), which represents a year on year growth of 14%.

 

The revenues for the nine months ended 30 September 2013 include, for the first time, $4.8 million from m2mAIR, Telit's Platform as a Service (PaaS), the Company's value added, connectivity and cloud platform services business unit. This business unit was empowered by the recent acquisition of ILS Technology LLC, leading provider of a ready-to-use, off-the-shelf, cloud platform to connect enterprise IT systems to m2m-connected devices and machines for business-critical use. This acquisition is anticipated to provide Telit with access to additional value added services and customers, granting Telit an even broader footprint in the m2m value chain. Telit's PaaS opens new opportunities to expand our services offering to small and medium m2m customers worldwide, widening our market advantage and will support Telit's recurring revenue strategy.

 

The Board continues to expect that trading for the full year 2013 will be in line with market expectations.

 

 

For further information:

Telit Communications PLC

Tel: +39 06 4204601

Oozi Cats, CEO

Yosi Fait, Finance Director

Canaccord Genuity Limited

Nominated Adviser

Simon Bridges

Peter Stewart

 

Tel: +44 20 7523 8000

Notes to editors

Telit is a global enabler of machine-to-machine (M2M) communications providing cellular, short range and positioning modules via its brand Telit Wireless Solutions. Through its business unit m2mAIR, Telit provides platform as a service (PaaS) including M2M managed and value added services, application enablement and connectivity including mobile network side and cloud backend services. Telit is M2M's top one-stop-shop offering synergistic hardware and value added services bundles along with low-entry cost PaaS for rapid application development. With over 12 years exclusively in M2M, the company constantly advances technology through seven R&D centers around the globe; marketing products and services in over 80 countries.

 

By supplying scalable products interchangeable across families, technologies and generations, rapid prototyping tools for application development, and m2m tailored connectivity, Telit is able to curb development costs, protect design investments and reduce technical risk. The company provides customer support and design-in assistance through 32 sales and support offices, a global distributor network of experts with over 30 competence centers, and the Telit Technical Support Forum.

 

Telit provides all products services and facilities to connect organizations to the Internet of Things (IoT) allowing them to wirelessly collect, process and respond to real-world data from connected devices, creating new efficiencies, revenue streams, societal and personal benefits.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMMGGLLLGFZM
Date   Source Headline
9th Aug 20191:35 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSBlock listing return
18th Jul 201910:43 amRNSHolding(s) in Company
17th Jul 20197:00 amRNSHalf year trading update
2nd Jul 20192:00 pmRNSChange of Adviser
2nd Jul 20198:00 amRNSGrant of Options
1st Jul 20192:00 pmRNSDirectorate Changes
1st Jul 20197:30 amRNSResponse to AIM censure
24th Jun 20198:17 amRNSHolding(s) in Company
21st Jun 20196:27 pmRNSHolding(s) in Company
6th Jun 201912:25 pmRNSResult of AGM
29th May 20192:31 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSPaolo Dal Pino appointed Chief Executive Officer
15th May 20193:54 pmRNSHolding(s) in Company
13th May 20197:00 amRNSNotice of AGM
8th May 20193:32 pmRNSHolding(s) in Company
8th May 201910:58 amRNSHolding(s) in Company
8th May 20197:00 amRNSUpdate on Italian VAT Assessment
7th May 20194:23 pmRNSHolding(s) in Company
3rd May 20199:46 amRNSHolding(s) in Company
2nd May 20197:00 amRNSDirector/PDMR Shareholding
26th Apr 20191:47 pmRNSHolding(s) in Company
18th Apr 20198:19 amRNSHolding(s) in Company
16th Apr 20197:00 amRNSYear end results
15th Apr 201910:22 amRNSVendor Loan repaid
11th Apr 20197:00 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSTotal Voting Rights
19th Mar 20194:05 pmRNSBAMES settlement agreement
13th Mar 20192:39 pmRNSNotice of Results
27th Feb 201911:37 amRNSAutomotive division sale completed
21st Feb 20192:34 pmRNSUpdate on Automotive deal
20th Feb 20193:10 pmRNSUpdate: Automotive deal
1st Feb 20199:00 amRNSBlock Listing Return
1st Feb 20197:00 amRNSUpdate on sale of automotive division
16th Jan 20192:48 pmRNSDirector/PDMR Shareholding
15th Jan 20197:00 amRNSYear end trading update
27th Dec 20187:00 amRNSUpdate on sale of automotive division
18th Dec 20187:00 amRNSFCA investigation
11th Dec 20187:00 amRNSUpdate:sale of automotive, trading & 2019 outlook
6th Nov 201810:04 amRNSHolding(s) in Company
6th Nov 20188:58 amRNSHolding(s) in Company
5th Nov 20183:46 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTotal Voting Rights
31st Oct 20181:29 pmRNSHolding(s) in Company
26th Oct 20187:00 amRNSHolding(s) in Company
24th Oct 20187:00 amRNSDirector/PDMR Shareholding
18th Oct 20189:36 amRNSDirector/PDMR Shareholding
17th Oct 20185:57 pmRNSHolding(s) in Company
17th Oct 20182:42 pmRNSHolding(s) in Company
17th Oct 201810:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.